|
ARL5A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.42679987216832E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64039892780465E-11 |
| Normal-vs-Stage2 |
4.716800E-03 |
| Normal-vs-Stage3 |
5.69670000000189E-05 |
| Normal-vs-Stage4 |
6.375000E-01 |
| Stage1-vs-Stage2 |
2.096000E-01 |
| Stage1-vs-Stage3 |
3.742000E-01 |
| Stage1-vs-Stage4 |
1.604200E-01 |
| Stage2-vs-Stage3 |
6.466200E-01 |
| Stage2-vs-Stage4 |
4.050400E-01 |
| Stage3-vs-Stage4 |
2.854600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.13740178071021E-11 |
| Normal-vs-AfricanAmerican |
2.0607999999922E-05 |
| Normal-vs-Asian |
1.966030E-01 |
| Caucasian-vs-AfricanAmerican |
3.505000E-01 |
| Caucasian-vs-Asian |
6.433600E-01 |
| AfricanAmerican-vs-Asian |
9.084000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.74179576212441E-11 |
| Normal-vs-Female |
3.76240000000694E-05 |
| Male-vs-Female |
4.806400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.1010999996558E-07 |
| Normal-vs-Extreme_Weight |
1.23000498675196E-11 |
| Normal-vs-Obese |
4.25029999995274E-06 |
| Normal-vs-Extreme_Obese |
5.5609000000012E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.834200E-01 |
| Normal_Weight-vs-Obese |
2.734400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.571200E-01 |
| Extreme_Weight-vs-Obese |
6.486400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.533200E-01 |
| Obese-vs-Extreme_Obese |
4.671800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.732100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.57430000036207E-07 |
| Normal-vs-Age(61-80Yrs) |
2.04769534661864E-11 |
| Normal-vs-Age(81-100Yrs) |
2.561900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.272000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.210400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.578800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.657600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.240400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.762600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.028099910234E-11 |
| Normal-VS-Type2 PRCC |
4.4474000004957E-07 |
| Normal-VS-KIRP CIMP |
6.708000E-01 |
| Normal-VS-Unclassified PRCC |
2.339600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.901400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.075810E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.107600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.508000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.425400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.552800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.21880000536478E-08 |
| Normal-vs-N1 |
3.370200E-01 |
| Normal-vs-N2 |
3.421200E-04 |
| N0-vs-N1 |
2.965600E-02 |
| N0-vs-N2 |
8.215000E-01 |
| N1-vs-N2 |
2.602200E-01 |
|
|
